What is Aleo BME?
Headquartered in State College, Pennsylvania, Aleo BME operates at the intersection of biotechnology research and advanced device manufacturing. The company leverages intellectual property derived from Penn State University to engineer high-performance solutions, including biodegradable medical devices for peripheral nerve regeneration and sophisticated bioimaging tools. By focusing on fluorescent molecules and anti-microbial coatings, Aleo BME addresses critical, unmet needs in both clinical healthcare and environmental protection sectors. Its market position is defined by a commitment to translating complex material science into scalable, life-enhancing applications, effectively bridging the gap between academic innovation and commercial utility.
How much funding has Aleo BME raised?
Aleo BME has raised a total of $65K across 1 funding round:
Debt
$65K
Debt (2021): $65K with participation from PPP
Key Investors in Aleo BME
PPP
Public-Private Partnership
What's next for Aleo BME?
Following this significant Series B/C stage financing, Aleo BME is poised to transition from a research-heavy entity into a more robust commercial operation. The strategic deployment of this capital will likely focus on scaling manufacturing capabilities for its biodegradable nerve regeneration portfolio and expanding its footprint in the medical sensing market. As the company matures, stakeholders will be monitoring its ability to navigate regulatory pathways and achieve broader clinical adoption. The focus remains on optimizing its proprietary material technologies to capture market share in the high-growth segments of regenerative medicine and advanced bio-sensing, ensuring long-term value creation for its investors and partners.
See full Aleo BME company page
